Free Trial

CymaBay Therapeutics (CBAY) Institutional Ownership

→ The Weight Loss Pill That Could Disrupt a $32 Billion Industry (From Behind the Markets) (Ad)
Free CBAY Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial MediaSustainability

Institutional Ownership Changes (13F Filings) for CymaBay Therapeutics (NASDAQ:CBAY)

Current
Institutional Ownership
Percentage
95.03%
Number of
Institutional Buyers
(last 12 months)
91
Total
Institutional Inflows
(last 12 months)
$542.06M
Number of
Institutional Sellers
(last 12 months)
39
Total
Institutional Outflows
(last 12 months)
$133.66M
Get CBAY Insider Trade Alerts

Want to know when executives and insiders are buying or selling CymaBay Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CBAY Institutional Buying and Selling by Quarter

CymaBay Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/22/2024PNC Financial Services Group Inc.8,179$193K0.0%+1,833.6%0.007%
3/11/2024Vanguard Group Inc.6,306,149$148.95M0.0%+9.7%5.497%
3/5/2024Wellington Management Group LLP202,782$4.79M0.0%N/A0.177%
3/4/2024Tucker Asset Management LLC3,749$89K0.0%N/A0.003%
2/26/2024Perceptive Advisors LLC4,024,400$95.06M2.1%-0.5%3.549%
2/20/2024Quarry LP4,000$94K0.0%-55.6%0.004%
2/15/2024Octagon Capital Advisors LP2,673,750$63.15M10.1%-11.3%2.358%
2/15/2024Clear Street Markets LLC8,405$199K0.0%N/A0.007%
2/15/2024Comerica Bank69,260$1.64M0.0%+5,019.0%0.061%
2/14/2024Avoro Capital Advisors LLC11,111,111$262.44M3.6%+7.9%9.798%
2/14/2024Vestal Point Capital LP1,625,000$38.38M4.1%N/A1.433%
2/13/2024Affinity Asset Advisors LLC1,090,441$25.76M4.8%-3.4%0.962%
2/13/2024NEOS Investment Management LLC15,189$359K0.0%N/A0.013%
2/13/2024Campbell & CO Investment Adviser LLC21,714$513K0.0%-39.9%0.019%
2/12/2024TD Asset Management Inc157,556$3.72M0.0%+71.3%0.139%
2/12/2024Steward Partners Investment Advisory LLC17,600$416K0.0%+14.7%0.016%
2/9/2024Westfield Capital Management Co. LP700,056$16.54M0.1%N/A0.617%
2/9/2024US Bancorp DE28,986$685K0.0%-35.7%0.026%
2/9/2024Franklin Resources Inc.3,267,927$77.19M0.0%-1.2%2.882%
2/8/2024Nicholas Investment Partners LP434,507$10.26M1.2%-76.4%0.383%
2/8/2024 First Turn Management LLC1,497,331$35.37M5.1%N/A1.320%
2/8/2024Moran Wealth Management LLC22,246$525K0.0%N/A0.020%
2/7/2024 Principal Financial Group Inc.13,068$309K0.0%+26.3%0.012%
2/7/2024 Cary Street Partners Investment Advisory LLC13,900$328K0.0%-30.5%0.012%
2/7/2024 BNP Paribas Financial Markets169,082$3.99M0.0%+162.9%0.149%
2/7/2024 Teacher Retirement System of Texas18,430$435K0.0%-20.3%0.016%
2/6/2024Charles Schwab Investment Management Inc.853,475$20.16M0.0%+6.9%0.753%
2/6/2024AJOVista LLC1,794$42K0.1%N/A0.002%
2/6/2024 Amalgamated Bank16,279$385K0.0%+9.5%0.014%
2/6/2024Swiss National Bank155,400$3.67M0.0%-14.4%0.137%
2/5/2024 Victory Capital Management Inc.689,603$16.29M0.0%-33.5%0.608%
2/5/2024Russell Investments Group Ltd.111,550$2.64M0.0%+2,621.4%0.098%
2/2/2024Golden State Equity Partners54,289$1.28M0.3%+8.6%0.048%
2/2/2024Harvest Fund Management Co. Ltd1,076$26K0.0%N/A0.001%
2/1/2024New York State Common Retirement Fund95,043$2.25M0.0%+47.6%0.084%
2/1/2024 Jennison Associates LLC3,992,711$94.31M0.1%+12.3%3.521%
1/31/2024 Wetzel Investment Advisors Inc.3,000$71K0.0%N/A0.003%
1/31/2024Calamos Advisors LLC56,825$1.34M0.0%N/A0.050%
1/29/2024 Clarius Group LLC8,938$211K0.0%N/A0.008%
1/26/2024 Moody Aldrich Partners LLC261,415$6.18M1.1%-19.8%0.231%
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)

See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.

Click to read
1/25/2024 Allspring Global Investments Holdings LLC80,029$1.89M0.0%N/A0.071%
1/25/2024 International Assets Investment Management LLC133,311$3.15M0.0%N/A0.118%
1/25/2024 Strategic Blueprint LLC15,800$373K0.0%-6.0%0.014%
1/25/2024 Nisa Investment Advisors LLC1,211$29K0.0%-42.1%0.001%
1/24/2024 Mirae Asset Global Investments Co. Ltd.48,669$1.15M0.0%+1.1%0.043%
1/24/2024 International Assets Investment Management LLC133,311$3.15M0.0%N/A0.118%
1/24/2024 China Universal Asset Management Co. Ltd.13,114$310K0.1%+421.2%0.012%
1/17/2024 Assenagon Asset Management S.A.746,353$17.63M0.0%N/A0.658%
1/16/2024 Raymond James Financial Services Advisors Inc.113,883$2.69M0.0%+12.4%0.100%
1/16/2024 Raymond James & Associates57,286$1.35M0.0%+45.0%0.051%
1/16/2024 Legato Capital Management LLC40,393$954K0.1%+96.8%0.036%
1/12/2024 SG Americas Securities LLC4,780$113K0.0%-69.1%0.004%
12/18/2023Vanguard Group Inc.5,747,587$85.70M0.0%+11.6%5.068%
12/7/2023Hudson Bay Capital Management LP30,000$447K0.0%N/A0.026%
12/6/2023Citigroup Inc.18,414$275K0.0%-62.1%0.016%
11/24/2023Deutsche Bank AG456,106$6.80M0.0%-44.8%0.402%
11/15/2023RA Capital Management L.P.6,940,000$103.48M2.0%N/A6.120%
11/15/2023Baker Avenue Asset Management LP32,800$489K0.0%-37.9%0.029%
11/15/2023Seven Eight Capital LP41,556$620K0.1%N/A0.037%
11/15/2023Acuta Capital Partners LLC418,000$6.23M4.2%-2.8%0.369%
11/15/2023Adage Capital Partners GP L.L.C.4,125,000$61.50M0.1%-6.3%3.638%
11/15/2023Alps Advisors Inc.72,461$1.08M0.0%+1.1%0.064%
11/15/2023Affinity Asset Advisors LLC1,129,376$16.84M4.7%+7.5%0.996%
11/15/2023Glenmede Trust Co. NA37,894$565K0.0%N/A0.033%
11/14/2023MPM Bioimpact LLC610,770$9.11M2.4%N/A0.539%
11/14/2023Gotham Asset Management LLC40,462$603K0.0%N/A0.036%
11/14/2023Corton Capital Inc.16,080$240K0.1%-4.7%0.014%
11/14/2023Fred Alger Management LLC2,172,309$32.39M0.2%N/A1.916%
11/14/2023Lynx1 Capital Management LP994,161$14.82M9.8%-17.5%0.877%
11/14/2023Trexquant Investment LP219,755$3.28M0.1%+289.1%0.194%
11/14/2023Monashee Investment Management LLC75,000$1.12M0.5%N/A0.066%
11/14/2023OMERS ADMINISTRATION Corp24,900$371K0.0%N/A0.022%
11/14/2023Profund Advisors LLC18,961$283K0.0%-4.0%0.017%
11/13/2023 Cary Street Partners Investment Advisory LLC20,000$298K0.0%-33.3%0.018%
11/13/2023Algert Global LLC92,886$1.39M0.1%N/A0.082%
11/13/2023EAM Investors LLC381,564$5.69M1.1%+2.4%0.336%
11/13/2023ClariVest Asset Management LLC96,481$1.44M0.1%-39.7%0.085%
11/13/2023Invesco Ltd.941,808$14.04M0.0%+2.1%0.831%
11/13/2023FMR LLC1,568,948$23.39M0.0%+13,559.7%1.384%
11/13/2023Rafferty Asset Management LLC10,424$155K0.0%N/A0.009%
11/13/2023Atika Capital Management LLC116,000$1.73M0.2%N/A0.102%
11/9/2023Rhumbline Advisers129,504$1.93M0.0%+2.8%0.117%
11/9/2023Deutsche Bank AG456,106$6.80M0.0%-44.8%0.413%
11/8/2023Campbell & CO Investment Adviser LLC36,115$538K0.1%-69.0%0.033%
11/8/2023Charles Schwab Investment Management Inc.798,555$11.91M0.0%+201.6%0.724%
11/8/2023Swiss National Bank181,500$2.71M0.0%+14.2%0.164%
11/8/2023J.P. Morgan Private Wealth Advisors LLC10,627$158K0.0%N/A0.010%
11/8/2023 Moody Aldrich Partners LLC325,977$4.86M0.9%+182.6%0.295%
11/7/2023Virtus ETF Advisers LLC11,343$169K0.1%-9.0%0.010%
11/7/2023New York State Common Retirement Fund64,404$960K0.0%+39.9%0.058%
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (Ad)

See how with its ongoing expansion and development of its diverse and promising product pipeline, this small-cap NYSE company is positioned to be a dominant and innovative leader in the nanomedicine and antiviral therapy space.

Click to read
11/7/2023Jump Financial LLC63,684$950K0.0%N/A0.058%
11/7/2023Arizona State Retirement System22,212$331K0.0%+8.4%0.020%
11/6/2023 Victory Capital Management Inc.1,037,433$15.47M0.0%+2,028.1%0.940%
11/2/2023 Principal Financial Group Inc.10,345$154K0.0%-10.7%0.009%
11/1/2023Orion Portfolio Solutions LLC15,334$229K0.0%N/A0.014%
10/31/2023 Teacher Retirement System of Texas23,135$345K0.0%+16.6%0.021%
10/31/2023 Jennison Associates LLC3,555,274$53.01M0.0%+112.7%3.222%
10/31/2023 China Universal Asset Management Co. Ltd.2,516$38K0.0%+96.9%0.002%
10/27/2023 Hennion & Walsh Asset Management Inc.72,839$1.09M0.1%+89.5%0.066%
10/27/2023TD Asset Management Inc91,956$1.37M0.0%N/A0.083%
(Data available from 1/1/2016 forward)

CBAY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CBAY shares?

During the previous two years, 139 institutional investors and hedge funds held shares of CymaBay Therapeutics. The most heavily invested institutionals were Avoro Capital Advisors LLC ($262.44M), Vanguard Group Inc. ($148.95M), RA Capital Management L.P. ($103.48M), Perceptive Advisors LLC ($95.06M), Jennison Associates LLC ($94.31M), Franklin Resources Inc. ($77.19M), and Octagon Capital Advisors LP ($63.15M).Learn more on CBAY's institutional investors.

What percentage of CymaBay Therapeutics stock is owned by institutional investors?

95.03% of CymaBay Therapeutics stock is owned by institutional investors. Learn more on CBAY's institutional investor holdings.

Which institutional investors have been buying CymaBay Therapeutics stock?

Of the 111 institutional investors that purchased CymaBay Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($6.94M), Jennison Associates LLC ($3.99M), Cormorant Asset Management LP ($2.53M), Bain Capital Life Sciences Investors LLC ($2.50M), Fred Alger Management LLC ($2.17M), Vestal Point Capital LP ($1.63M), and Laurion Capital Management LP ($1.62M).

How much institutional buying is happening at CymaBay Therapeutics?

Institutional investors have bought a total of 41,464,841 shares in the last 24 months. This purchase volume represents approximately $574.67M in transactions.

Which CymaBay Therapeutics major shareholders have been selling company stock?

Of the 50 institutional investors that sold CymaBay Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Commodore Capital LP ($3.71M), Nicholas Investment Partners LP ($1.41M), Great Point Partners LLC ($1.04M), Logos Global Management LP ($850K), Deutsche Bank AG ($739.70K), Lynx1 Capital Management LP ($474.74K), and Altium Capital Management LP ($405K).

How much institutional selling is happening at CymaBay Therapeutics?

Institutional investors have sold a total of 12,008,842 shares in the last 24 months. This volume of shares sold represents approximately $142.51M in transactions.


Related Companies:
This page (NASDAQ:CBAY) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners
The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way
Smallcaps Daily
AI “wealth window” is closing June 25th
Paradigm Press
Gold Set to EXPLODE!
Gold Safe Exchange
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
Forget Bitcoin: This $8 Stock Is the Next Big Thing
Behind the Markets
Charles Payne Demystifies Options
Unstoppable Prosperity
The AI Stock that’s Disrupting Every Industry
StockEarnings